Project Grant R35GM161455
- Federal Project Grant Award Summary The Medical College of Wisconsin, Inc. received a $506,105 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through July 31, 2030. The award supports research investigating the functional dynamics of essential bacterial proteins and the development of transformative electron paramagnetic resonance (EPR) spectroscopy...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $572,553 to the University of Wisconsin–Milwaukee under the Biomedical Research and Research Training program (CFDA 93.859) on September 1, 2025, for a three-year project period concluding August 31, 2028. The research investigates the evolution of pleiotropic consequences resulting from mucoid-based phage resistance in Escherichia coli populations. The project aims to characterize how...
- Federal Project Grant Award Summary The Medical College of Wisconsin, Inc. received a $390,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025, through July 31, 2030. The grant supports fundamental research on the structural dynamics of G protein-coupled receptor (GPCR) oligomerization and its impact on localization and signaling pathways. This five-year...
- Federal Project Grant Award Summary The University of Wisconsin-Milwaukee received a $563,880 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) effective September 1, 2025, through August 31, 2028. The award supports fundamental basic research investigating regulators of the unfolded protein response (UPR) signaling pathway, with particular focus on the IRE1 pathway using budding yeast...
- Summary of Federal Project Grant Award The National Institute of General Medical Sciences (NIGMS) awarded The Medical College of Wisconsin, Inc. a Project Grant totaling $429,000 under the Biomedical Research and Research Training program (CFDA 93.859), effective August 15, 2025, with a completion date of July 31, 2030. This research initiative, titled "Clarifying Engineered Bioabsorbable Metals Tissue-Biomaterial Interface and Regeneration," focuses on developing a technical design...
- Federal Project Grant Award Summary The Medical College of Wisconsin, Inc. received a $649,014 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 5, 2026, through January 31, 2031. This award funds investigator-initiated biomedical research examining the conformation and functional dynamics of Class B penicillin-binding proteins (PBPs) in enterococcal antimicrobial...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Washington University a Project Grant totaling $416,050 under the Biomedical Research and Research Training program (CFDA 93.859) to investigate the metabolic and regulatory mechanisms controlling antibiotic production in filamentous actinobacteria. The award, announced on August 5, 2025, with completion targeted for May 31, 2030, supports fundamental basic research aimed at unlocking the...
- Federal Project Grant Award Summary The University of Washington received a $427,625 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2030. This award funds research to develop a novel nano-prodrug delivery platform that targets microbiome-modulating molecules to the distal gastrointestinal tract while integrating physiologically-based...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Washington University a Project Grant totaling $326,550 under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2030. This five-year award supports fundamental research aimed at developing ecological theory and computational methodologies to predict and design microbial ecosystem functions. The research addresses a...
- Federal Project Grant Award Summary Washington State University received a $382,500 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 1, 2025, with completion scheduled for May 31, 2030. The award supports fundamental research investigating the molecular and neuronal mechanisms that regulate and limit stress responses in living organisms. The research employs Caenorhabditis...
The Medical College of Wisconsin, Inc. received a $390,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026, through March 31, 2031. This award supports a five-year research initiative titled "Metabolic Regulation of Immunity in C. elegans," which investigates how purine nucleotide metabolism regulates intestinal epithelial defense pathways in the model organism Caenorhabditis elegans. The research will employ genetic and biochemical experiments to elucidate the mechanisms by which cellular metabolites control intracellular pathogen response pathways, including a type I interferon-like defense program comparable to systems relevant to human health. The project deliverables include development of visualization tools to assess purine nucleotide metabolic flux in intestinal tissue, characterization of how purine metabolites regulate transcription of genes involved in pathogen defense, and investigation of how post-translational modification of defense proteins with uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) affects RNA interference protein function. The research outcomes are anticipated to advance fundamental understanding of epithelial defense mechanisms and provide insights applicable to human disorders resulting from dysregulation of purine metabolism and post-translational modifications, including immunodeficiency, cancer, diabetes, autoimmunity, and neurodegenerative disease.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $390.0k | 3/24/26 |